He has been engaged in pediatric surgery for 29 years and has accumulated rich medical experience. He is skilled in the clinical diagnosis and surgical treatment of common and multiple diseases in pediatric surgery, and is skilled in the surgical treatment of pediatric esophageal atresia, esophageal stenosis, pediatric thoracic deformity, congenital common bile duct cyst, biliary atresia, congenital megacolon, and radical surgery for malignant tumors of the lung, mediastinum, liver, and kidney in pediatric patients, especially in the surgical treatment of hemangioma, congenital common bile duct cyst, congenital megacolon, and various minimally invasive and plastic surgery. Three month old Doudou was born with a small red spot on the outer edge of the right cheek, and the hospital diagnosed it as a hemangioma. In this regard, Xu Quan, director of pediatric surgery at the Second Affiliated Hospital of Xi’an Jiaotong University, said that hemangioma is a common pediatric vascular lesion, which is a benign tumor that can gradually subside on its own over time, and that observation, oral medication, and topical medication can be used as conventional treatment methods with good results. Many parents are too worried about their children’s condition and often go around seeking medical help. Director Xu reminded that hemangioma is a benign tumor, most of which appear in infancy, and the cause is still unclear, mostly thought to be viruses and estrogen. More than 60% of them can fade away naturally, so invasive treatment is not recommended. If they do not occur on the face, do not affect the aesthetics, and do not change much over a long period of time, they can be left untreated for a while and observed. There are different treatment options for different types of hemangiomas. About 20 – 40% of hemangiomas will increase in size, spread, affect aesthetics, and in some cases, even affect function. The treatment of pediatric hemangioma is understood differently as a whole, so it is emphasized that it is best to seek out a specialist with more experience in carrying out the treatment of hemangioma for the first consultation to determine the treatment plan. For example, laser and isotope treatment of hemangioma carried out by some hospitals are not the preferred treatment options for pediatric hemangioma. Conventional treatment: observation + oral medicine + topical medicine Director Xu emphasized that the harm of hemangioma depends on its growth site, size and tissue composition. Symptomatic treatment is based on the site, size, depth, and presence of skin invasion of the tumor. If a large hemangioma grows rapidly, it is important to seek medical attention as soon as possible. The treatment plan can be determined based on ultrasound. There are many treatment methods for pediatric hemangioma, including freezing, laser, surgical excision, herbal medicine, oral hormone, local hormone injection, oral medicine, interferon, local hormone injection and oral, sclerosing agent, pinyamycin, imiquimod, isotope dressing, electrochemical treatment, etc. The principles of treatment for pediatric hemangioma should be followed: safe, convenient, minimally invasive or non-invasive, and economical. This is the most respected treatment concept at present. New use of old drugs for reliable efficacy It is best to actively intervene in hemangioma of the face to avoid affecting the aesthetics and increasing the psychological burden of parents in the future. Oral drugs, such as propranolol (Takeaway), which is routinely used in the treatment of cardiovascular disease, are now used in the treatment of hemangioma with very good results. The topical drug Imiquimod, which is an antiviral drug, is now used for hemangioma treatment, and the cost is very economical, about 200 yuan for domestic drugs and 500 yuan for imported drugs, and it can be applied only once every other day under the guidance of a doctor. It should be emphasized that these two drugs are still only the most promising treatments. It should be emphasized that these two drugs are still only in the clinical trial stage and must be treated under the close observation and guidance of a specialist physician and should not be used on their own.